Shopping on line can be easy, simple and save you lots of money. It can also take a lot of your time, frustrate you, and result in unwanted purchases. Now the same can be said for regular high street shopping, but with the vast opportunity presented by the Internet it will pay you to spend a few minutes reading this and understanding how to better optimize your Glycosylation shopping experience:
1. Compare - without doubt the biggest advantage that the Glycosylation offers shoppers today is the ability to compare thousands of Glycosylation at a time. This is a great thing, but not necessarily all the time! Too much can be daunting at times so take advantage of the great comparison sites and where possible let them do the hard work for you.
2. Research - if it has been said it will be on the internet. Ignorance is no longer a justifiable reason for buying the wrong thing. Take the time to research in detail everything that you could possible want to know about
3. Testimonials - don't know anybody that has bought a Glycosylation? Wrong! If the Glycosylation is good the internet will let you know. Use the Internet as a friend and get testimonials before you buy.
4. Questions - Got a question about Glycosylation then search the Forums, FAQ's, Blogs etc. Don't be afraid to ask .....
5. Reputation - Never heard of the company selling Glycosylation? Don't worry, no reason why you should know every company in the world, but you know someone that does! Use the internet to find out what people are saying about Glycosylation and build up a picture of their reputation for sales, returns, customer service, delivery etc.
6. Returns - still worried that even after all of the above your Glycosylation wont be what you want? Check out the returns policy. There is so much competition now that someone, somewhere is bound to offer the terms that you are comfortable with.
7. Feedback - happy with your Glycosylation then let people know, after all you are depending on others people input in your buying decision, so why not give a little back.
8. Security - check for the yellow padlock on the Glycosylation site before you buy, and the s after http:/ /i.e. https:// = a secure site
9. Contact - got a question about Glycosylation, or want to leave a comment then check out the sites contact page. Reputable companies have them and respond.
10. Payment - ready to pay for your Glycosylation, then use your credit card or PayPal! Be aware of companies that don't accept them, there may be genuine reasons but given the huge amount of choice you have when buying online there is no reason at all not to buy via credit card or PayPal.
Glycosylation is the process or result of addition of saccharides to
proteins and
lipids. The process is one of four principal co-translational and post-translational modification steps in the synthesis of membrane and secreted proteins and the majority of proteins synthesized in the rough endoplasmic reticulum undergo glycosylation. It is an enzyme-directed site-specific process, as opposed to the non-enzymatic chemical reaction of
glycation. Two types of glycosylation exist:
N-linked glycosylation to the
amide nitrogen of asparagine
side chains and
O-linked glycosylation to the hydroxy
oxygen of
serine and
threonine side chains.
Purpose
The polysaccharide chains attached to the target proteins serve various functions. For instance, some proteins do not fold correctly unless they are glycosylated first. Also, polysaccharides linked at the amide nitrogen of asparagine in the protein confer stability on some secreted glycoproteins. Experiments have shown that glycosylation in this case is not a strict requirement for proper folding, but the unglycosylated protein degrades quickly. Glycosylation may play a role in cell-cell adhesion (a mechanism employed by cells of the immune system), as well.
Mechanisms
There are various mechanisms for glycosylation, although all share several common features:
- Glycosylation is an enzymatic process
- The donor molecule is an activated nucleotide sugar
- The process is site-specific
N-linked glycosylation
N-linked glycosylation is important for the folding of some of eukaryotic proteins. The
N-linked glycosylation process occurs in eukaryotes and widely in
archaea, but very rarely in bacteria.
For
N-linked oligosaccharides, a 14-sugar precursor is first added to the asparagine in the polypeptide chain of the target protein. The structure of this precursor is common to most eukaryotes, and contains 3
glucose, 9 mannose, and 2
N-acetylglucosamine molecules. A complex set of reactions attaches this branched chain to a carrier molecule called dolichol, and then it is transferred to the appropriate point on the polypeptide chain as it is translocated into the ER lumen.
There are two major types of
N-linked saccharides: high-mannose oligosaccharides, and complex oligosaccharides.
- High-mannose is, in essence, just two N-acetylglucosamines with many mannose residues, often almost as many as are seen in the precursor oligosaccharides before it is attached to the protein.
- Complex oligosaccharides are so named because they can contain almost any number of the other types of saccharides, including more than the original two N-acetylglucosamines.
Proteins can be glycosylated by both types of oligos on different portions of the protein. Whether an oligosaccharide is high-mannose or complex is thought to depend on its accessibility to saccharide-modifying proteins in the
Golgi apparatus. If the saccharide is relatively inaccessible, it will most likely stay in its original high-mannose form. If it is accessible, then it is likely that many of the mannose residues will be cleaved off and the saccharide will be further modified by the addition of other types of group as discussed above.
The
oligosaccharide chain is attached by oligosaccharyltransferase to
asparagine occurring in the tripeptide sequence Asn-X-serine or Asn-X-threonine, where X could be any
amino acid except
proline. This sequence is known as a glycosylation
sequon. After attachment, once the protein is correctly folded, the three glucose residues are removed from the chain and the protein is available for export from the ER. The glycoprotein thus formed is then transported to the Golgi where removal of further mannose residues may take place. However, glycosylation itself does not seem to be as necessary for correct transport targeting of the protein, as one might think. Studies involving drugs that block certain steps in glycosylation, or mutant cells deficient in a glycosylation enzyme, still produce otherwise-structurally-normal proteins that are correctly targeted, and this interference does not seem to interfere severely with the viability of the cells. Mature glycoproteins may contain a variety of oligomannose
N-linked oligosaccharides containing between 5 and 9 mannose residues. Further removal of mannose residues leads to a 'core' structure containing 3
mannose, and 2
N-acetylglucosamine residues, which may then be elongated with a variety of different monosaccharides including galactose,
N-acetylglucosamine, N-acetylgalactosamine,
fucose and
sialic acid.
O-linked glycosylation
O-N-acetylgalactosamine (
O-GalNAc)
O-linked glycosylation occurs at a later stage during protein processing, probably in the
Golgi apparatus. This is the addition of N-acetyl-galactosamine to
serine or
threonine residues by the enzyme
UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (), followed by other carbohydrates (such as galactose and
sialic acid). This process is important for certain types of proteins such as
proteoglycans, which involves the addition of glycosaminoglycan chains to an initially unglycosylated "proteoglycan core protein." These additions are usually serine
O-linked glycoproteins, which seem to have one of two main functions. One function involves secretion to form components of the
extracellular matrix, adhering one cell to another by interactions between the large sugar complexes of proteoglycans. The other main function is to act as a component of mucosal secretions, and it is the high concentration of carbohydrates that tends to give mucus its "slimy" feel. Proteins that circulate in the blood are not normally
O-glycosylated, with the exception of
IgA1 and
IgD (two types of antibody) and C1-inhibitor.
O-fucose
O-fucose is added between the second and third conserved cysteines of EGF-like repeats in the Notch protein, and possibly other substrates by GDP-fucose Protein O-fucosyltransferase 1, and to Thrombospondin repeats by GDP-fucose protein O-fucosyltransferase 2. In the case of EGF-like repeats, the
O-fucose may be further elongated to a tetrasaccharide by sequential addition of N-acetylglucosamine (GlcNAc), galactose, and sialic acid, and for Thrombospondin repeats, may be elongated to a disaccharide by the addition of
glucose. Both of these fucosyltransferases have been localized to the
endoplasmic reticulum, which is unusual for glycosyltransferases, most of which function in the Golgi apparatus.
O-glucose
O-glucose is added between the first and second conserved cysteines of EGF-like repeats in the
Notch protein, and possibly other substrates by an unidentified
O-glucosyltransferase.
O-
N-acetylglucosamine (
O-GlcNAc)
O-GlcNAc is added to serines or threonines by
O-GlcNAc transferase.
O-GlcNAc appears to occur on serines and threonines that would otherwise be phosphorylated by serine/threonine kinases. Thus, if phosphorylation occurs,
O-GlcNAc does not, and
vice versa. This is an incredibly important finding because phosphorylation/dephosphorylation has become a scientific paradigm for the regulation of signaling within cells. A massive amount of cancer research is focused on phosphorylation. Ignoring the involvement of this form of glycosylation which clearly appears to act in concert with phosphorylation means that a lot of current research is missing at least half of the picture.
O-GlcNAc addition and removal also appear to be key regulators of the pathways which are deregulated in diabetes mellitus. The gene encoding the
O-GlcNAc removal enzyme has been linked to non-insulin dependent diabetes mellitus. It is the terminal step in a nutrient sensing hexosamine signaling pathway.
GPI anchor
A special form of glycosylation is the
GPI anchor. This form of glycosylation functions to attach a protein to a hydrophobic lipid anchor, via a glycan chain. (see also
prenylation)
C-mannosylation
A
mannose sugar is added to
tryptophan residues in
Thrombospondin repeats. This is an unusual modification both because the sugar is linked to a carbon rather than a reactive atom like a nitrogen or oxygen and because the sugar is linked to a tryptophan residue rather than an
asparagine or
serine/threonine.
See also
External links
- GlyProt: In-silico N-glycosylation of proteins on the web
Glycosylation is the process or result of addition of saccharides to
proteins and
lipids. The process is one of four principal co-translational and post-translational modification steps in the synthesis of membrane and secreted proteins and the majority of proteins synthesized in the rough
endoplasmic reticulum undergo glycosylation. It is an enzyme-directed site-specific process, as opposed to the non-enzymatic chemical reaction of glycation. Two types of glycosylation exist:
N-linked glycosylation to the
amide nitrogen of asparagine side chains and
O-linked glycosylation to the hydroxy oxygen of
serine and
threonine side chains.
Purpose
The polysaccharide chains attached to the target proteins serve various functions. For instance, some proteins do not fold correctly unless they are glycosylated first. Also, polysaccharides linked at the amide nitrogen of asparagine in the protein confer stability on some secreted glycoproteins. Experiments have shown that glycosylation in this case is not a strict requirement for proper folding, but the unglycosylated protein degrades quickly. Glycosylation may play a role in cell-cell adhesion (a mechanism employed by cells of the immune system), as well.
Mechanisms
There are various mechanisms for glycosylation, although all share several common features:
- Glycosylation is an enzymatic process
- The donor molecule is an activated nucleotide sugar
- The process is site-specific
N-linked glycosylation
N-linked glycosylation is important for the folding of some of eukaryotic proteins. The
N-linked glycosylation process occurs in eukaryotes and widely in
archaea, but very rarely in
bacteria.
For
N-linked oligosaccharides, a 14-sugar precursor is first added to the asparagine in the polypeptide chain of the target protein. The structure of this precursor is common to most eukaryotes, and contains 3
glucose, 9 mannose, and 2
N-acetylglucosamine molecules. A complex set of reactions attaches this branched chain to a carrier molecule called dolichol, and then it is transferred to the appropriate point on the polypeptide chain as it is translocated into the ER lumen.
There are two major types of
N-linked saccharides: high-mannose oligosaccharides, and complex oligosaccharides.
- High-mannose is, in essence, just two N-acetylglucosamines with many mannose residues, often almost as many as are seen in the precursor oligosaccharides before it is attached to the protein.
- Complex oligosaccharides are so named because they can contain almost any number of the other types of saccharides, including more than the original two N-acetylglucosamines.
Proteins can be glycosylated by both types of oligos on different portions of the protein. Whether an oligosaccharide is high-mannose or complex is thought to depend on its accessibility to saccharide-modifying proteins in the Golgi apparatus. If the saccharide is relatively inaccessible, it will most likely stay in its original high-mannose form. If it is accessible, then it is likely that many of the mannose residues will be cleaved off and the saccharide will be further modified by the addition of other types of group as discussed above.
The
oligosaccharide chain is attached by
oligosaccharyltransferase to
asparagine occurring in the tripeptide sequence Asn-X-
serine or Asn-X-
threonine, where X could be any
amino acid except proline. This sequence is known as a glycosylation
sequon. After attachment, once the protein is correctly folded, the three glucose residues are removed from the chain and the protein is available for export from the ER. The glycoprotein thus formed is then transported to the Golgi where removal of further mannose residues may take place. However, glycosylation itself does not seem to be as necessary for correct transport targeting of the protein, as one might think. Studies involving drugs that block certain steps in glycosylation, or mutant cells deficient in a glycosylation enzyme, still produce otherwise-structurally-normal proteins that are correctly targeted, and this interference does not seem to interfere severely with the viability of the cells. Mature glycoproteins may contain a variety of oligomannose
N-linked oligosaccharides containing between 5 and 9 mannose residues. Further removal of mannose residues leads to a 'core' structure containing 3 mannose, and 2
N-acetylglucosamine residues, which may then be elongated with a variety of different monosaccharides including
galactose,
N-acetylglucosamine, N-acetylgalactosamine,
fucose and sialic acid.
O-linked glycosylation
O-N-acetylgalactosamine (
O-GalNAc)
O-linked glycosylation occurs at a later stage during protein processing, probably in the
Golgi apparatus. This is the addition of N-acetyl-galactosamine to
serine or
threonine residues by the enzyme
UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (), followed by other carbohydrates (such as galactose and sialic acid). This process is important for certain types of proteins such as
proteoglycans, which involves the addition of glycosaminoglycan chains to an initially unglycosylated "proteoglycan core protein." These additions are usually serine
O-linked glycoproteins, which seem to have one of two main functions. One function involves secretion to form components of the
extracellular matrix, adhering one cell to another by interactions between the large sugar complexes of proteoglycans. The other main function is to act as a component of mucosal secretions, and it is the high concentration of carbohydrates that tends to give mucus its "slimy" feel. Proteins that circulate in the blood are not normally
O-glycosylated, with the exception of
IgA1 and
IgD (two types of antibody) and
C1-inhibitor.
O-fucose
O-fucose is added between the second and third conserved cysteines of EGF-like repeats in the Notch protein, and possibly other substrates by
GDP-fucose Protein O-fucosyltransferase 1, and to Thrombospondin repeats by GDP-fucose protein O-fucosyltransferase 2. In the case of EGF-like repeats, the
O-
fucose may be further elongated to a tetrasaccharide by sequential addition of N-acetylglucosamine (GlcNAc), galactose, and
sialic acid, and for Thrombospondin repeats, may be elongated to a disaccharide by the addition of glucose. Both of these fucosyltransferases have been localized to the
endoplasmic reticulum, which is unusual for glycosyltransferases, most of which function in the
Golgi apparatus.
O-glucose
O-glucose is added between the first and second conserved cysteines of EGF-like repeats in the
Notch protein, and possibly other substrates by an unidentified
O-glucosyltransferase.
O-
N-acetylglucosamine (
O-GlcNAc)
O-GlcNAc is added to serines or threonines by
O-GlcNAc transferase.
O-GlcNAc appears to occur on serines and threonines that would otherwise be phosphorylated by serine/threonine kinases. Thus, if
phosphorylation occurs,
O-GlcNAc does not, and
vice versa. This is an incredibly important finding because phosphorylation/dephosphorylation has become a scientific paradigm for the regulation of signaling within cells. A massive amount of cancer research is focused on phosphorylation. Ignoring the involvement of this form of glycosylation which clearly appears to act in concert with phosphorylation means that a lot of current research is missing at least half of the picture.
O-GlcNAc addition and removal also appear to be key regulators of the pathways which are deregulated in diabetes mellitus. The gene encoding the
O-GlcNAc removal enzyme has been linked to non-insulin dependent diabetes mellitus. It is the terminal step in a nutrient sensing
hexosamine signaling pathway.
GPI anchor
A special form of glycosylation is the
GPI anchor. This form of glycosylation functions to attach a protein to a hydrophobic lipid anchor, via a glycan chain. (see also prenylation)
C-mannosylation
A
mannose sugar is added to
tryptophan residues in
Thrombospondin repeats. This is an unusual modification both because the sugar is linked to a
carbon rather than a reactive atom like a nitrogen or
oxygen and because the sugar is linked to a
tryptophan residue rather than an
asparagine or serine/threonine.
See also
External links
- GlyProt: In-silico N-glycosylation of proteins on the web
Glycosylation - Wikipedia, the free encyclopedia
Glycosylation is the process or result of addition of saccharides to proteins and lipids. The process is one of four principal co-translational and post-translational modification ...
Glycosylation Predictor
Welcome to the web interface of GPP, the Hirst group glycosylation prediction server. This server predicts the location of N-linked and O-linked glycosylation sites from
glycosylation - definition of glycosylation in the Medical dictionary ...
glycosylation /gly·co·syl·a·tion/ (gli-ko?si-la´shun) the formation of linkages with glycosyl groups. gly·co·sy·la·tion (gl k-s-l sh n) n. The addition of glycosyl groups ...
Glycosylation
Description of this file ... SEB Marseille 2008 - Glycosylation. TOPIC: What’s new in experimental glycobiology?
Glycosylation: Study glycosylation using SimGlycan
Glycosylation study: Use SimGlycan to predit the glycan structures and accelerate your slycosylation study.
Glycosylation :: Molecules of HIV
An article from "The Molecules of HIV" (c) Dan Stowell www.mcld.co.uk/hiv
Definition: glycosylation from Online Medical Dictionary
The Online Medical Dictionary is a searchable dictionary of definitions from medicine, science and technology.
GO:0006486 protein amino acid glycosylation
The European Bioinformatics Institute ... You can reach the search box using alt+9 (Win/IE), alt+shift+9 (Win/Firefox) or ctrl+9 (Mac)
BioMed Central | Abstract | Glycosylation site prediction using ...
Cornelia Caragea 1,2, Jivko Sinapov 1,2, Adrian Silvescu 1,2, Drena Dobbs 3,4 and Vasant Honavar 1,2. 1 Artificial Intelligence Research Laboratory, Computer Science Department ...
Electrochemical Glycosylation
Grants on the web ... Summary: The project aims to investigate and develop the use of electrochemical glycosylation, in particular in line with the principle of reactivity tuning ...
